Dernières nouvelles
Information non disponible
- Néron, HélèneEmployéHôpital de l'Enfant-Jésus+1 418-649-5624helene.neron@chudequebec.ca
1401, 18e Rue
Québec, Québec
Canada G1J 1Z4
Post-procedural bleeding rate and haemostatic treatment use for dental procedures before and after the implementation of a standardized protocol for people with inherited bleeding disorders
Article de revueHaemophilia, 28 (5), 2022.
Evaluation of anti-factor VIII antibodies in haemophilia A subjects switching products following a provincial tender
Article de revueHaemophilia, 28 (1), 2022.
A prospective surveillance study in haemophilia B patients following a population switch to recombinant factor IX (nonacog gamma)
Article de revueHaemophilia, 27 (4), 2021.
Neurodevelopmental outcomes of singleton large for gestational age infants <29 weeks' gestation: a retrospective cohort study
Article de revueJ Perinatol, 41 (6), 2021.
Relapse pattern and long-term outcomes in subjects with acquired haemophilia A
Article de revueHaemophilia, 25 (2), 2019.
N 163- Prise en charge gynécologique et obstétricale des femmes présentant une coagulopathie héréditaire
Article de revueJ Obstet Gynaecol Can, 40 (2), 2018.
No. 163-Gynaecological and Obstetric Management of Women With Inherited Bleeding Disorders
Article de revueJ Obstet Gynaecol Can, 40 (2), 2018.
A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third-generation B-domain-deleted recombinant factor VIII
Article de revueHaemophilia, 24 (2), 2018.
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial
Article de revueLancet, 384 (9955), 2014.
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
Article de revueLancet, 383 (9920), 2014.